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Summary Using growth delay and clonogenic cell survival as end points, we have shown that the 3-
dimensional structure of human lung tumour spheroids confers a degree of resistance to the anthracyclines
adriamycin and 4'-deoxydoxorubicin, relative to cells grown as monolayer. 4'-deoxydoxorubicin induces a
longer growth delay and greater clonogenic cell kill than adriamycin in spheroids, although it is no more
cytotoxic in monolayer (exponential and plateau phase). There is a log linear relationship between clonogenic
cell survival and duration of adriamycin exposure in monolayers, and a biphasic curve with a lesser degree of
cell kill for disaggregated spheroid cells. Using fluorescent microscopy we have demonstrated, qualitatively,
that the more lipophilic analogue partitions into the spheroid more rapidly and to a greater degree than
adriamycin. It is possible that adriamycin penetration is a relatively important aspect of spheroid drug
resistance, which may be related to intraspheroidal pH gradients, and that we have partially overcome this by
using a lipophilic analogue.
The multicellular spheroid model was developed as
a system of intermediate complexity between solid
tumours and monolayers in which 3-dimensional
growth of cells creates microenvironments that
simulate micrometastatic foci (Sutherland et al.,
1981). Resistance of intact spheroid cells to drug
treatment has been reported for a number of
cytotoxic agents and the existence of drug
penetration barriers has been postulated (Nederman
et al., 1981).
Fluorescent microscopic (Sutherland et al., 1979)
and flow cytometric (Durand, 1981) studies have
shown that adriamycin is localised within the outer
cell layers of V79 Chinese Hamster spheroids and
that the inner spheroid core cells are relatively
resistant to the cytotoxic effects of the drug. We
have recently shown that 4'-deoxydoxorubicin (4'-
deoxy), a lipophilic derivative of adriamycin is
taken up more rapidly and to a greater extent than
the parent drug by human lung tumour cells grown
as monolayers, although its cytotoxic activity in
this system is similar to that of adriamycin (Kerr et
al., 1985). In this present study we have assessed
differential penetration of the two drugs in human
lung tumour spheroids by fluorescent microscopy
and have compared their cytocidal effects in
spheroid and monolayer.
Materials and methods
Cell culture
The L-DAN cell line was derived from our own
patient with squamous lung cancer. The cells were
maintained as a monolayer in exponential growth
in Ham's FIO/DMEM (50:50) with 8mM NaHCO3
supplemented with foetal calf serum. The mono-
layers were disaggregated enzymatically with 0.25%
trypsin in PBS and the resultant cell suspension
used to provide cells for initiation of tumour
spheroids, using the 'agar underlay' static method
(Yuhas et al., 1977).
During growth delay experiments, spheroid size
was monitored by twice weekly measurement of
cross-sectional areas of individual spheroids using a
'Micromeasurements' image analysis system coupled
via a television camera to an inverted optical
microscope (Twentyman, 1982). These area
measurements were subsequently converted to
volumes, assuming spherical geometry.
Conditions ofdrug exposure and determination of
cell survival
L-DAN monolayers and spheroids were exposed to
both drugs over a range of concentrations (0.1-
20pgml-1) for 1 h, or at a fixed drug concentration
of 10 igml- I for varying periods of time (15min-
2h). The monolayers were treated in both the
exponential and plateau phase of growth.
Exponentially growing cells were harvested on day
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3, plateau phase cells on day 7. The drugs were
kindly supplied by Farmitalia Carlo Erba and were
administered to the cells in culture medium after
dissolution in normal saline.
After treatment, the monolayer cells were
harvested with 0.25% trypsin in PBS, centrifuged
and washed with ice cold medium. The cells were
then diluted in medium and seeded at 200cellsml-1
in 5cm petri dishes. The plates were incubated for
12 days in a humid 2% CO2 atmosphere. The
colonies were then fixed and stained with methylene
blue and colonies of .40 cells were counted.
Following the usual convention the cloning
efficiency of the untreated cells was normalised to
100% and the cloning efficiency of the treated cells
was expressed as a percentage ofcontrol survival.
Spheroids from two flasks were pooled and a
number of glass universal tubes were prepared, each
containing two to three hundred spheroids with a
mean diameter of -350pm. The spheroids were
treated with similar drug concentrations and
durations of exposure as used in monolayer at 37°C
with intermittent agitation. At the end of this
period the spheroids were allowed to sediment, the
drug containing medium was removed and they
were washed with fresh, ice cold medium. The
spheroids were then resuspended in medium and
subdivided for assays of response.
Approximately half of the spheroids were
incubated with 0.125% trypsin in PBS for 15min at
37°C, after which the trypsin was removed and
replaced with fresh medium. The spheroids were
then mechanically disaggregated to a single cell
suspension by repeated pipetting. The clonogenic
assay was repeated as previously described.
A pasteur pipette was used to transfer spheroids
from the other group to agar coated wells on a
plastic tissue culture multidish with 1 spheroid per
well. Twenty-four spheroids were taken from each
treatment group, and area measurements were
made twice weekly as described. It was possible
therefore to measure treatment induced growth
delay, which we defined as the time taken for
median spheroid volumes to increase by a factor of
10 above initial size.
Determination ofintracellular drug levels
The pH of adriamycin containing culture medium
(5pgml-1) was adjusted to give a range from pH
5.5-8.5 (pH meter; Inio Electronics Ltd). The
monolayers were exposed for 30min to the drug
containing culture medium, and incubated at 37°C.
The cells were then washed twice with ice cold PBS
and harvested by a brief exposure to trypsin and
counted by a Coulter Counter. Adriamycin was
extracted from the resulting cell suspension by
vortexing with organic solvents (chloroform and
isopropanol) and measured by an HPLC technique
with fluorescence detection, previously described by
our laboratory (Cummings et al., 1984). Extracted
drug was expressed as ng 10 cells.
Fluorescent microscopy
Intact spheroids - 500pm in diameter were exposed
to adriamycin and 4'-deoxy for varying times
(30min to 4h) with a medium concentration of
5pgml -1. The spheroids were then washed to
remove loosely bound drug, placed in gelatin
capsules filled with OCT embedding gel (Lurker
Labs, Ltd) and frozen in liquid nitrogen. Thin
sections (6pm) were subsequently cut using a
cryotome, mounted in uvinert and examined under
a Polyvar fluorescent microscope (A excitation=
486nm; A emission=550nm).
Results
Effect ofpH on adriamycin uptake in monolayer
Intracellular adriamycin levels have been plotted
against extracellular pH (Figure 1). The curve was
fitted by non-linear least squares and is sigmoidal
in shape. There is a 7.5-fold difference in intra-
cellular drug levels from pH 5.5 to pH 8.5. Fifty per
cent of total drug uptake occurred at approximately
pH7.5.
Cell survival in spheroids and monolayers
Each experiment was repeated at least 4 times, but
for the sake of clarity the results of 2 experiments
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Figure 1 The relationship between intracellular
adriamycin levels and extracellular pH. Each point is
the mean of 5 experiments (the vertical bars represent
s.d.).
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are shown in each figure. All the curves were fitted
by eye to the data shown.
Based on extracellular drug concentrations, there
is no significant difference in clonogenic cell
survival after treatment of monolayers in the
exponential or plateau phase of growth with the
two drugs (Figure 2). On the basis of external drug
concentration, plateau phase cells are considerably
more resistant to both drugs than exponentially
growing cells. The respective exponential ID50s for
adriamycin and 4'-deoxy are 2.3jgml-1 and
2.2,ugml 1 and the plateau phase. ID50s are
3.2pgmPm1 and 3.5pgml-1. Typical spheroid
growth delay data after treatment with a range of
adriamycin concentrations are shown in Figure 3.
The control curve follows Gompertzian kinetics and
the treated spheroids regrow at a rate parallel to
control. It is apparent that 4'-deoxy induces
relatively larger delays in growth for equivalent
drug concentrations (Table I). Clonogenic cell
survival after disaggregation of treated spheroids
was significantly higher for a given dose than for
monolayer, and differed for the two drugs (Figure
4). Adoption of spheroid configuration confers a
degree of resistance to drug treatment, relative to
monolayer, which is partially overcome by 4'-
deoxy.
The longer the duration of exposure of the
monolayers to adriamycin, the greater the
clonogenic cell kill. There is an apparent log linear
relationship between the duration of adriamycin
exposure in monolayer and clonogenic cell kill at
fixed drug concentration (Figure 5). Clonogenic cell
survival after disaggregation of intact spheroids
decreased with increasing duration of exposure but
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Figure 2 Clonogenic survival of monolayer cells in
the plateau (A, 0) or exponential (A, 0) phase of
growth after exposure to adriamycin (0, 0) or 4'-
deoxy (A, A). Each point is the mean of 4
experiments (the vertical bars represent s.d.).
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Figure 3 Growth delay after spheroid exposure to adriamycin; 0 0, control; 0-0, 1uggml-'; *---@,
2pgml-1; x x,5jgml-'; x --- x,1Opgml-l x.*x, 15ygmI-1.
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Table I Growth delay of L-DAN spheroids exposed to
different concentrations of adriamycin or 4'-deoxy for a
fixed time (1 h)
Concentration Median growth 95% Confidence
(igml-1) delay (days)a limitsb
Adriamycin
0 (control) 8.1 6.3-8.9
5 11.5 10.0-14.2
5 13.1 12.0-14.9
10 17.3 15.4-18.3
12.5 16.4 15.3-17.9
20 17.4 14.5-19.2
4'-deoxy
0 (control) 6.4 5.0-6.8
1 15.9 13.0-18.5
5 19.4 15.4-20.5
10 24.9 NAC
15 29.5 NA
aThe growth delay was taken to be time to reach x 10
original volume.; bApproximate 95% confidence limits on
medium spheroid volumes were calculated by the method
of Nair (cited by Colquhoun, 1971). Growth curves were
constructed for each experimental group using upper and
lower limits on median volume. Growth delay values were
obtained from each of these curves and are referred to as
95% confidence limits on median spheroid growth delay.
CNA - not assessable (upper bound required extrapolation
beyond available data).
was higher than for monolayer and the spheroid
cell survival curve is biexponential. Spheroid
growth delay, as a function of drug exposure time,
is summarised in Table II. It is apparent that a
plateau phase is achieved with no further significant
increases in growth delay with drug exposures of
greater than 90min (Figure 6).
Fluorescent microscopy
It was possible to evaluate the degree of penetra-
tion qualitatively using fluorescent microscopy.
Sections stained with haematoxylin and eosin showed
that there are approximately 10-12 cell layers from
the outer layer to the centre in spheroids - 300-
400gm in diameter with a necrotic centre. After
drug exposure (5pgml-1 for 2h) adriamycin was
seen in the nuclei of the outer 3-4 cells, whereas
4'-deoxy had penetrated further to a depth of 6-7
cell layers (Figure 7). Prolongation of drug expo-
sure times did not appear to significantly enhance
further drug penetration.
Discussion
We have shown that the 3-dimensional structure of
the spheroid confers a degree of resistance to the
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Figure 4 Clonogenic cell survival of monolayers
(A, O) and spheroids (A, 0) after exposure to adria-
mycin (0, 0) or 4'-deoxy (A, A).
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Figure 5 The relationship between clonogenic cell
survival and the duration of adriamycin (10ygml-1)
exposure; 0-0, monolayer; 0---O, disaggregated
spheroids.
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Table II Growth delay of L-DAN spheroids exposed to
a fixed concentration of adriamycin (10pgml-') for
different lengths of time
Adriamycin Median growth 95% Confidence
exposure time delaya limitsb
(min) (days) (days)
0 8.5 7.0-10.2
15 10.6 9.0-12.0
30 13.0 11.3-14.5
60 20.4 19.0-26.5
90 27.5 22.2-30.2
120 27.5 19.5-30.0
aThe growth delay was taken to be time to reach x 5
original spheroid volume. bApproximate 95% confidence
limits on medium spheroid volumes were calculated by the
method of Nair (cited by Colquhoun, 1971). Growth
curves were constructed for each experimental group using
upper and lower limits on median volume. Growth delay
values were obtained from each of these curves and are
referred to as 95% confidence limits on median spheroid
growth delay.
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Figure 6 Growth delay as a function of duration of
adriamycin (10pgml-1) exposure.
anthracyclines adriamycin and 4-deoxydoxorubicin,
relative to the monolayer. A number of factors
have been considered relevant to cytotoxic drug
resistance in spheroids, including - intrinsic cellular
drug resistance; failure of drug penetration;
alteration in cell cycle kinetics; microenvironmental
changes within the spheroid which could affect the
physicochemical properties of the drug; protection
of spheroid cells by intercellular communication;
drug resistance of central hypoxic cells (Wibe,
1980). One would expect that the phenomenon of
(B)
Figure 7 Fluorescent photomicrographs of sections
from spheroids exposed to: (A), 5pgml-' adriamycin;
(B) 5ygmlP' 4'-deoxy, for 2h. The external cells show
highest levels of intracellular drug. (Mag. x 100).
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drug resistance in cells grown as spheroids is likely
to be a combination of these factors. We have
compared identical cells in monolayer and spheroid,
therefore the difference in spheroid sensitivity is
unlikely to be due to intrinsic drug resistance.
The cell cycle distribution is not identical when
comparing cells grown as spheroids and monolayer.
Actively cycling cells tend to predominate on the
exterior layers of the spheroid, whereas plateau
phase cells tend to make up the majority of internal
cells (Kerr, unpublished data). Chambers et al.
(1984) have shown that there is a complex
relationship between intracellular adriamycin levels
and the proliferative state of EMT6 cells. For a
given intracellular concentration of drug, plateau
phase cells were found to be relatively more
resistant than exponentially growing cells. We have
shown that human lung tumour plateau phase cells
are significantly more resistant to adriamycin and
4'-deoxy, but to a similar degree (Figure 2).
It is possible that the degree of resistance
confered by adoption of spheroid configuration
could be explained, at least in part, by the
unfavourable proliferative state of spheroid cells.
Nevertheless, despite both drugs having identical
effects on monolayer cells in both phases of
growth, 4'-deoxy is significantly more toxic to
multicellular spheroids. Kwok and Twentyman
(1985) have compared the response to adriamycin
of EMT6 cells, treated as intact or disaggregated
spheroids. In that study, the cell cycle distribution
of the two cell populations was identical, and yet it
was apparent that the sensitivity of disaggregated
spheroid cells was greater than that of intact
spheroids.
The duration of drug exposure is an important
determinant of survival. There is a linear
relationship between the two for monolayer, at
least over the times used in these experiments.
However, the clonogenic cell survival curve was
biphasic, for disaggregated spheroid cells, with a
lesser degree of cell kill. This plateau effect is also
seen when spheroid growth delay is plotted against
time (Figure 6) with no further apparent increase in
growth delay with drug exposures of greater than
90min. Fluorescent microscopy shows that even
after prolonged exposure to adriamycin (up to 4h)
the drug does not reach the centre of the spheroid.
This may explain the disparity in shape between the
monolayer and disaggregated spheroid cell survival
curves.
Adriamycin is a basic drug (pK8) and the amino
group of the daunosamine sugar moiety is likely to
be protonated at acidic pH (the amount of ionised
drug can be derived from the Henderson-
Hasselbach equation). There is some evidence to
suggest that adriamycin enters the cell by diffusion
of the electroneutral molecule through the lipid
domain of the cell membrane (Dalmark, 198la,b).
We have shown the dependence of cellular drug
uptake on external pH, in monolayer (Figure 1).
Using microelectrodes, Acker et al. (1982) have
demonstrated significant gradients in oxygen, pH
and glucose from the external to internal spheroid
cell layers. There is some histological evidence of
central necrosis in spheroids of 400gm in
diameter, which would be likely to be associated
with a relatively acidic pH. This pH gradient may
therefore influence adriamycin ionisation and hence
be a contributory factor to the failure of the drug
to penetrate to the centre of the spheroid core.
4'-deoxy induced a longer growth delay and
greater clonogenic cell kill than adriamycin. There
is no difference in the cell cycle specificity of the
two drugs, but we have demonstrated that the
lipophilic analogue partitions into the spheroid
more rapidly; and to a greater degree. It is tempting
to speculate that adriamycin penetration is a
relatively important aspect of spheroid drug
resistance in our model system, and that we have
partially overcome this by using a lipophilic
analogue. The 3-dimensional spheroid model may
be an important additional method by which new
lipophilic analogues of existing cytotoxic drugs
should be assessed preclinically, as part of the
selection procedure for further development.
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